MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
CDTX Cidara Therapeutics
- 23.2200
- +0.7100+3.15%
Close Dec 20 16:00 ET
- 23.2200
- 0.00000.00%
Post 20:01 ET
254.00MMarket Cap-1.00P/E (TTM)
24.0000High21.2000Low148.36KVolume22.1200Open22.5100Pre Close3.35MTurnover3.00%Turnover RatioLossP/E (Static)10.94MShares24.990052wk High2.20P/B114.91MFloat Cap10.000052wk Low--Dividend TTM4.95MShs Float382.6000Historical High--Div YieldTTM12.44%Amplitude8.0000Historical Low22.6050Avg Price1Lot Size
Cidara Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | -94.07%302K | -67.58%8.46M | -0.84%63.91M | 317.94%43.38M | -77.38%9.22M | -18.11%5.09M | 267.24%26.11M | 30.01%64.45M | 43.65%10.38M |
| Operating revenue | --0 | -94.07%302K | -67.58%8.46M | -0.84%63.91M | 317.94%43.38M | -77.38%9.22M | -18.11%5.09M | 267.24%26.11M | 30.01%64.45M | 43.65%10.38M |
| Cost of revenue | 1.56M | 1.52M | 0 | 0 | 0 | |||||
| Gross profit | -73.57%6.9M | -3.21%62.38M | 26.11M | 64.45M | 10.38M | |||||
| Operating expense | 27.10%17.39M | -3.67%11.4M | -24.59%17.59M | -11.32%86.87M | 74.91%47.98M | -47.00%13.69M | -38.76%11.84M | -8.06%23.33M | 6.67%97.95M | 14.32%27.43M |
| Selling and administrative expenses | 50.50%4.97M | 49.20%4.75M | 34.57%6M | -10.77%18.33M | 49.42%8.2M | -42.92%3.3M | -21.92%3.18M | -14.35%4.46M | 9.64%20.55M | 10.16%5.49M |
| -General and administrative expense | ---- | 49.20%4.75M | 34.57%6M | -10.77%18.33M | ---- | ---- | -21.92%3.18M | -14.35%4.46M | 9.64%20.55M | 10.16%5.49M |
| Research and development costs | 19.67%12.43M | -23.10%6.66M | -38.56%11.59M | -11.46%68.53M | 81.28%39.78M | -48.18%10.39M | -43.25%8.66M | -6.43%18.87M | 5.91%77.41M | 15.41%21.94M |
| Operating profit | -289.30%-17.39M | -64.51%-11.1M | -484.43%-10.69M | 26.92%-24.48M | 64.09%-6.12M | -129.94%-4.47M | 48.54%-6.75M | 115.23%2.78M | 20.71%-33.5M | -1.68%-17.05M |
| Net non-operating interest income expense | 203.26%1.86M | 184.75%1.77M | 57.33%365K | 944.50%2M | 225.31%527K | 1,014.55%613K | 10,483.33%623K | 1,260.00%232K | 190.09%191K | 590.91%162K |
| Non-operating interest income | 203.26%1.86M | ---- | 57.33%365K | 944.50%2M | 225.31%527K | 1,014.55%613K | ---- | --232K | --191K | --162K |
| Total other finance cost | ---- | -184.75%-1.77M | ---- | ---- | ---- | ---- | -10,483.33%-623K | ---- | ---- | ---- |
| Other net income (expense) | -84.88M | |||||||||
| Special income (charges) | ---- | ---84.88M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Less:Other special charges | ---- | --84.88M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -302.98%-15.54M | -1,438.12%-94.21M | -442.71%-10.33M | 32.49%-22.49M | 66.86%-5.6M | -125.74%-3.86M | 53.31%-6.13M | 116.48%3.01M | 21.56%-33.31M | -0.52%-16.89M |
| Income tax | 0 | 0 | 62.87%443K | 59.93%435K | -32K | 40K | 272K | 272K | ||
| Net income | -75.52%-15.99M | -569.47%-91.21M | -442.71%-10.33M | 31.72%-22.93M | 81.28%-3.21M | -160.80%-9.11M | -3.85%-13.62M | 116.48%3.01M | 20.92%-33.58M | -2.14%-17.16M |
| Net income continuous Operations | -306.36%-15.54M | -1,428.14%-94.21M | -442.71%-10.33M | 31.72%-22.93M | 64.85%-6.03M | -125.52%-3.82M | 53.01%-6.17M | 116.48%3.01M | 20.92%-33.58M | -2.14%-17.16M |
| Net income discontinuous operations | 91.48%-450K | 140.23%3M | ---- | ---- | ---- | ---5.28M | ---7.46M | ---- | ---- | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -75.52%-15.99M | -569.47%-91.21M | -442.71%-10.33M | 31.72%-22.93M | 81.28%-3.21M | -160.80%-9.11M | -3.85%-13.62M | 116.48%3.01M | 20.92%-33.58M | -2.14%-17.16M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 636K | ||||||||
| Net income attributable to common stockholders | -75.52%-15.99M | -569.47%-91.21M | -534.41%-10.33M | 31.72%-22.93M | 81.28%-3.21M | -176.55%-9.11M | -3.85%-13.62M | 113.00%2.38M | 20.92%-33.58M | -2.14%-17.16M |
| Basic earnings per share | -21.29%-2.45 | -561.92%-19.99 | -480.00%-2.28 | 45.83%-5.2 | 83.16%-0.64 | -159.41%-2.02 | 20.53%-3.02 | 111.11%0.6 | 40.74%-9.6 | 26.92%-3.8 |
| Diluted earnings per share | -21.29%-2.45 | -561.92%-19.99 | -480.00%-2.28 | 45.83%-5.2 | 83.16%-0.64 | -159.41%-2.02 | 20.53%-3.02 | 111.11%0.6 | 40.74%-9.6 | 26.92%-3.8 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.